BUSCETI, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 195
EU - Europa 82
AS - Asia 79
SA - Sud America 10
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 369
Nazione #
US - Stati Uniti d'America 186
SG - Singapore 48
IT - Italia 35
DE - Germania 21
CN - Cina 17
BR - Brasile 9
CA - Canada 7
GB - Regno Unito 7
FI - Finlandia 6
HK - Hong Kong 4
SE - Svezia 4
CZ - Repubblica Ceca 3
VN - Vietnam 3
IQ - Iraq 2
MX - Messico 2
NL - Olanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
ES - Italia 1
IN - India 1
LT - Lituania 1
PK - Pakistan 1
PT - Portogallo 1
TR - Turchia 1
Totale 369
Città #
Singapore 35
Chandler 32
Santa Clara 16
Hefei 12
Dallas 9
Lawrence 9
Princeton 9
Milan 8
Munich 8
Ashburn 7
Turku 6
Hong Kong 4
Redmond 4
London 3
Olomouc 3
Ottawa 3
Redwood City 3
Rome 3
Toronto 3
Wilmington 3
Baghdad 2
Boston 2
Chicago 2
Des Moines 2
Guangzhou 2
Johannesburg 2
Los Angeles 2
Mexico City 2
Norwalk 2
Rapallo 2
San Francisco 2
Settingiano 2
Acerra 1
Amsterdam 1
Ankara 1
Atlanta 1
Bandar Seri Begawan 1
Beijing 1
Belo Horizonte 1
Boardman 1
Brooklyn 1
Calgary 1
Capivari 1
Conceição do Castelo 1
Dalian 1
Gaithersburg 1
Glasgow 1
Goiânia 1
Halifax 1
Hanoi 1
Ho Chi Minh City 1
Itapetininga 1
Jaboatão dos Guararapes 1
Karlsruhe 1
Manchester 1
Mem Martins 1
Montería 1
Nagold 1
New York 1
Oak Lawn 1
Padova 1
Phoenix 1
Porto Alegre 1
Sindelfingen 1
São Paulo 1
The Bronx 1
Vado Ligure 1
Vienna 1
Waltham Forest 1
Yên Bái 1
Zaragoza 1
Totale 243
Nome #
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 52
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 46
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 44
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 39
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 36
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 34
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 34
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 33
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 26
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 19
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 15
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 11
Totale 389
Categoria #
all - tutte 4.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 3 0 9 1 2 0 2 2 0 1
2021/202226 1 0 0 4 2 0 4 3 3 4 5 0
2022/2023104 18 4 10 1 12 10 2 9 19 9 6 4
2023/202432 6 4 6 4 1 4 0 0 0 0 5 2
2024/2025111 17 1 1 1 15 23 2 2 4 0 24 21
2025/202674 30 41 3 0 0 0 0 0 0 0 0 0
Totale 389